42
The clinical use of itraconazole in patients receiving multiple doses of oxycodone for pain relief may increase the risk of opioid-associated adverse effects.
 patients: Subject; opioid-associated adverse effects: Effect; itraconazole: Treatment; receiving multiple doses of oxycodone: Treatment; pain relief: Treatment.Disorder; oxycodone: Treatment.Drug; itraconazole: Treatment.Drug; multiple doses: Treatment.Dosage; itraconazole: Combination.Drug; oxycodone: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients: Subject; opioid-associated adverse effects: Effect; itraconazole: Treatment; receiving multiple doses of oxycodone: Treatment; pain relief: Treatment.Disorder; oxycodone: Treatment.Drug; itraconazole: Treatment.Drug; multiple doses: Treatment.Dosage; itraconazole: Combination.Drug; oxycodone: Combination.Drug